English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5127]
News [14858]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
Combined therapy can reduce chance of recurrence in women with small, HER2  breast tumours
Combined therapy can reduce chance of recurrence in women with small, HER2 breast tumours
World leaders gathering at Davos face calls for bold action to turn the tide on cancer
World leaders gathering at Davos face calls for bold action to turn the tide on cancer
Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list
Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list
Scientists develop novel platform for treatment of breast and pancreatic cancer
Scientists develop novel platform for treatment of breast and pancreatic cancer
Poor metabolic health increases risk for postmenopausal breast cancer irrespective of BMI
Poor metabolic health increases risk for postmenopausal breast cancer irrespective of BMI
Sputum biomarker panel may help identify which patients with lung nodules have lung cancer
Sputum biomarker panel may help identify which patients with lung nodules have lung cancer
Biochemically modified constituent of yew demonstrates early effectiveness in bile duct cancer
Biochemically modified constituent of yew demonstrates early effectiveness in bile duct cancer
Revamped drug may overcome resistance in brain tumours
Revamped drug may overcome resistance in brain tumours
ASCO GI: Higher vitamin D levels associated with markedly improved survival in patients with advanced colorectal cancer
ASCO GI: Higher vitamin D levels associated with markedly improved survival in patients with advanced colorectal...
ASCO GI: Second-line ramucirumab added to standard chemotherapy delays disease progression, extends survival for patients with advanced colorectal cancer
ASCO GI: Second-line ramucirumab added to standard chemotherapy delays disease progression, extends survival for...
<1...13271328132913301331...1486>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top